Abstract
The classes, subclasses and light chain types of 78 serum monoclonal immunoglobulins (MoIg) from adult patients affected with various clinical forms of human immunodeficiency virus (HIV) infection were studied by a sensitive Western blot technique. The incidence of MoIg-containing sera was 26% in a systematic study. Most of these sera contained several (up to eight) detectable MoIg. These MoIg were IgG (91%) and IgM (9%) with a predominance of light chains of the lambda type (kappa:lambda ratio 0.6). The subclass distribution of monoclonal IgG was strikingly different from that observed in myeloma; much less IgG1 and much more IgG3 and IgG4.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aucouturier P., Couderc L. J., Gouet D., Danon F., Gombert J., Matheron S., Saimot A. G., Clauvel J. P., Preud'homme J. L. Serum immunoglobulin G subclass dysbalances in the lymphadenopathy syndrome and acquired immune deficiency syndrome. Clin Exp Immunol. 1986 Jan;63(1):234–240. [PMC free article] [PubMed] [Google Scholar]
- Bouscary D., Fior R., Intrator L., Picard C., Sobel A. Immunoglobulines monoclonales sériques et infection à HIV-1. Presse Med. 1987 Jun 20;16(24):1199–1199. [PubMed] [Google Scholar]
- Groopman J. E., Sullivan J. L., Mulder C., Ginsburg D., Orkin S. H., O'Hara C. J., Falchuk K., Wong-Staal F., Gallo R. C. Pathogenesis of B cell lymphoma in a patient with AIDS. Blood. 1986 Mar;67(3):612–615. [PubMed] [Google Scholar]
- Heriot K., Hallquist A. E., Tomar R. H. Paraproteinemia in patients with acquired immunodeficiency syndrome (AIDS) or lymphadenopathy syndrome (LAS). Clin Chem. 1985 Jul;31(7):1224–1226. [PubMed] [Google Scholar]
- Lefrere J. J., Fine J. M., Lambin P., Muller J. Y., Courouce A. M., Salmon C. Monoclonal gammopathies in asymptomatic HIV-seropositive patients. Clin Chem. 1987 Sep;33(9):1697–1698. [PubMed] [Google Scholar]
- Papadopoulos N. M., Costello R. Oligoclonal immunoglobulins in the sera of healthy subjects at risk for AIDS. Clin Biochem. 1987 Aug;20(4):257–258. doi: 10.1016/s0009-9120(87)80008-5. [DOI] [PubMed] [Google Scholar]
- Papadopoulos N. M., Lane H. C., Costello R., Moutsopoulos H. M., Masur H., Gelmann E. P., Fauci A. S. Oligoclonal immunoglobulins in patients with the acquired immunodeficiency syndrome. Clin Immunol Immunopathol. 1985 Apr;35(1):43–46. doi: 10.1016/0090-1229(85)90076-5. [DOI] [PubMed] [Google Scholar]
- Pelicci P. G., Knowles D. M., 2nd, Arlin Z. A., Wieczorek R., Luciw P., Dina D., Basilico C., Dalla-Favera R. Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis. J Exp Med. 1986 Dec 1;164(6):2049–2060. doi: 10.1084/jem.164.6.2049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sala P. G., Mazzolini S., Tonutti E., Crucil C., Pitzus E., Bramezza M. Monoclonal-oligoclonal immunoglobulins in HTLV III infected subjects: HTLV III-induced or HTLV III-associated? Boll Ist Sieroter Milan. 1987;66(1):14–17. [PubMed] [Google Scholar]
- Seligmann M., Chess L., Fahey J. L., Fauci A. S., Lachmann P. J., L'Age-Stehr J., Ngu J., Pinching A. J., Rosen F. S., Spira T. J. AIDS--an immunologic reevaluation. N Engl J Med. 1984 Nov 15;311(20):1286–1292. doi: 10.1056/NEJM198411153112005. [DOI] [PubMed] [Google Scholar]